Sign Out
Pharmacology: VaxiRab N contains highly concentrated, inactivated rabies virus that has been cultivated in primary chick embryo fibroblast cell cultures (PCEC).
VaxiRab N produces high titers of neutralizing antibodies against rabies virus whether given before or after exposure.
Pharmacokinetics: The inactivated virus contained in VaxiRab N vaccine undergo phagocytosis by macrophages and is then transported with them into the reticuloendothelial tissue, where they stimulate the immune system to produce virus-neutralizing anti-rabies antibodies.
Continue with Google